Struggling Ionis licenses Bicycle Therapeutics' platform in a bid to develop drugs that can cross blood-brain barrier

Attempting to rebound from setbacks earlier this year, Ionis has enlisted a new partner in a quest to create drugs that can cross the blood-brain barrier. And the technology comes from a British biotech primarily known for its efforts into oncology.